Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflexal V 2012/2013 Influenza Vaccine Immunogenicity and Safety
NCT01631110Phase 3Completed
- Sponsor
- Crucell
- Start
- Jul 2012
- Primary completion
- Aug 2012
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Inflexal V in influenza, sponsored by Crucell. Started Jul 2012; status: completed.
02
Drugs
Inflexal V
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01631110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631110.